 | • レポートコード：B-GIR08C1093 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、カーフィルゾミブの世界市場について調べ、まとめました。種類別セグメントは、10mg注射、30mg注射、60mg注射等、用途別セグメントは、無機化学品、軽工業原料、医学、食品、その他等に区分しました。カーフィルゾミブの世界市場概観、企業動向、企業別カーフィルゾミブシェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・カーフィルゾミブの市場概観 ・カーフィルゾミブの企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・カーフィルゾミブの企業別販売動向、市場シェア、市場集中度、競争動向 ・カーフィルゾミブの世界市場規模 ・カーフィルゾミブの北米市場分析（アメリカ、カナダ、メキシコ等） ・カーフィルゾミブのアメリカ市場規模推移 ・カーフィルゾミブのカナダ市場規模推移 ・カーフィルゾミブのメキシコ市場規模推移 ・カーフィルゾミブのヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・カーフィルゾミブのドイツ市場規模推移 ・カーフィルゾミブのイギリス市場規模推移 ・カーフィルゾミブのロシア市場規模推移 ・カーフィルゾミブのアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・カーフィルゾミブの日本市場規模推移 ・カーフィルゾミブの中国市場規模推移 ・カーフィルゾミブの韓国市場規模推移 ・カーフィルゾミブのインド市場規模推移 ・カーフィルゾミブの東南アジア市場規模推移 ・カーフィルゾミブの南米市場分析（ブラジル、アルゼンチン等） ・カーフィルゾミブの中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・カーフィルゾミブの種類別分析/販売量、売上、市場シェア（10mg注射、30mg注射、60mg注射） ・カーフィルゾミブの用途別分析/市場規模（無機化学品、軽工業原料、医学、食品、その他） ・カーフィルゾミブの市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・カーフィルゾミブの販売チャネル・代理店・貿易業者・ディーラー分析 |
Scope of the Report:
The worldwide market for Carfilzomib is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Carfilzomib in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Amgen
Natco
AstraZeneca
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
10mg Injection
30mg Injection
60mg Injection
Market Segment by Applications, can be divided into
Hospital
Clinic
Drug Center
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Carfilzomib product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Carfilzomib, with price, sales, revenue and global market share of Carfilzomib in 2017 and 2018.
Chapter 3, the Carfilzomib competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Carfilzomib breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Carfilzomib market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Carfilzomib sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Carfilzomib Introduction
1.2 Market Analysis by Type
1.2.1 10mg Injection
1.2.2 30mg Injection
1.2.3 60mg Injection
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Drug Center
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Business Overview
2.1.2 Carfilzomib Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Amgen Carfilzomib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Natco
2.2.1 Business Overview
2.2.2 Carfilzomib Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Natco Carfilzomib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 AstraZeneca
2.3.1 Business Overview
2.3.2 Carfilzomib Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 AstraZeneca Carfilzomib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Carfilzomib Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Carfilzomib Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Carfilzomib Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Carfilzomib Manufacturer Market Share in 2018
3.3.2 Top 6 Carfilzomib Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Carfilzomib Market Analysis by Regions
4.1 Global Carfilzomib Sales, Revenue and Market Share by Regions
4.1.1 Global Carfilzomib Sales and Market Share by Regions (2014-2019)
4.1.2 Global Carfilzomib Revenue and Market Share by Regions (2014-2019)
4.2 North America Carfilzomib Sales and Growth Rate (2014-2019)
4.3 Europe Carfilzomib Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Carfilzomib Sales and Growth Rate (2014-2019)
4.5 South America Carfilzomib Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Carfilzomib Sales and Growth Rate (2014-2019)
5 North America Carfilzomib by Country
5.1 North America Carfilzomib Sales, Revenue and Market Share by Country
5.1.1 North America Carfilzomib Sales and Market Share by Country (2014-2019)
5.1.2 North America Carfilzomib Revenue and Market Share by Country (2014-2019)
5.2 United States Carfilzomib Sales and Growth Rate (2014-2019)
5.3 Canada Carfilzomib Sales and Growth Rate (2014-2019)
5.4 Mexico Carfilzomib Sales and Growth Rate (2014-2019)
6 Europe Carfilzomib by Country
6.1 Europe Carfilzomib Sales, Revenue and Market Share by Country
6.1.1 Europe Carfilzomib Sales and Market Share by Country (2014-2019)
6.1.2 Europe Carfilzomib Revenue and Market Share by Country (2014-2019)
6.2 Germany Carfilzomib Sales and Growth Rate (2014-2019)
6.3 UK Carfilzomib Sales and Growth Rate (2014-2019)
6.4 France Carfilzomib Sales and Growth Rate (2014-2019)
6.5 Russia Carfilzomib Sales and Growth Rate (2014-2019)
6.6 Italy Carfilzomib Sales and Growth Rate (2014-2019)
7 Asia-Pacific Carfilzomib by Country
7.1 Asia-Pacific Carfilzomib Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Carfilzomib Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Carfilzomib Revenue and Market Share by Country (2014-2019)
7.2 China Carfilzomib Sales and Growth Rate (2014-2019)
7.3 Japan Carfilzomib Sales and Growth Rate (2014-2019)
7.4 Korea Carfilzomib Sales and Growth Rate (2014-2019)
7.5 India Carfilzomib Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Carfilzomib Sales and Growth Rate (2014-2019)
8 South America Carfilzomib by Country
8.1 South America Carfilzomib Sales, Revenue and Market Share by Country
8.1.1 South America Carfilzomib Sales and Market Share by Country (2014-2019)
8.1.2 South America Carfilzomib Revenue and Market Share by Country (2014-2019)
8.2 Brazil Carfilzomib Sales and Growth Rate (2014-2019)
8.3 Argentina Carfilzomib Sales and Growth Rate (2014-2019)
8.4 Colombia Carfilzomib Sales and Growth Rate (2014-2019)
9 Middle East and Africa Carfilzomib by Countries
9.1 Middle East and Africa Carfilzomib Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Carfilzomib Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Carfilzomib Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Carfilzomib Sales and Growth Rate (2014-2019)
9.3 Turkey Carfilzomib Sales and Growth Rate (2014-2019)
9.4 Egypt Carfilzomib Sales and Growth Rate (2014-2019)
9.5 Nigeria Carfilzomib Sales and Growth Rate (2014-2019)
9.6 South Africa Carfilzomib Sales and Growth Rate (2014-2019)
10 Global Carfilzomib Market Segment by Type
10.1 Global Carfilzomib Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Carfilzomib Sales and Market Share by Type (2014-2019)
10.1.2 Global Carfilzomib Revenue and Market Share by Type (2014-2019)
10.2 10mg Injection Sales Growth and Price
10.2.1 Global 10mg Injection Sales Growth (2014-2019)
10.2.2 Global 10mg Injection Price (2014-2019)
10.3 30mg Injection Sales Growth and Price
10.3.1 Global 30mg Injection Sales Growth (2014-2019)
10.3.2 Global 30mg Injection Price (2014-2019)
10.4 60mg Injection Sales Growth and Price
10.4.1 Global 60mg Injection Sales Growth (2014-2019)
10.4.2 Global 60mg Injection Price (2014-2019)
11 Global Carfilzomib Market Segment by Application
11.1 Global Carfilzomib Sales Market Share by Application (2014-2019)
11.2 Hospital Sales Growth (2014-2019)
11.3 Clinic Sales Growth (2014-2019)
11.4 Drug Center Sales Growth (2014-2019)
11.5 Other Sales Growth (2014-2019)
12 Carfilzomib Market Forecast (2019-2024)
12.1 Global Carfilzomib Sales, Revenue and Growth Rate (2019-2024)
12.2 Carfilzomib Market Forecast by Regions (2019-2024)
12.2.1 North America Carfilzomib Market Forecast (2019-2024)
12.2.2 Europe Carfilzomib Market Forecast (2019-2024)
12.2.3 Asia-Pacific Carfilzomib Market Forecast (2019-2024)
12.2.4 South America Carfilzomib Market Forecast (2019-2024)
12.2.5 Middle East and Africa Carfilzomib Market Forecast (2019-2024)
12.3 Carfilzomib Market Forecast by Type (2019-2024)
12.3.1 Global Carfilzomib Sales Forecast by Type (2019-2024)
12.3.2 Global Carfilzomib Market Share Forecast by Type (2019-2024)
12.4 Carfilzomib Market Forecast by Application (2019-2024)
12.4.1 Global Carfilzomib Sales Forecast by Application (2019-2024)
12.4.2 Global Carfilzomib Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Carfilzomib Picture
Table Product Specifications of Carfilzomib
Figure Global Sales Market Share of Carfilzomib by Types in 2018
Table Carfilzomib Types for Major Manufacturers
Figure 10mg Injection Picture
Figure 30mg Injection Picture
Figure 60mg Injection Picture
Figure Carfilzomib Sales Market Share by Applications in 2018
Figure Hospital Picture
Figure Clinic Picture
Figure Drug Center Picture
Figure Other Picture
Figure United States Carfilzomib Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Carfilzomib Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Carfilzomib Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Carfilzomib Revenue (Value) and Growth Rate (2014-2024)
Figure France Carfilzomib Revenue (Value) and Growth Rate (2014-2024)
Figure UK Carfilzomib Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Carfilzomib Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Carfilzomib Revenue (Value) and Growth Rate (2014-2024)
Figure China Carfilzomib Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Carfilzomib Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Carfilzomib Revenue (Value) and Growth Rate (2014-2024)
Figure India Carfilzomib Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Carfilzomib Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Carfilzomib Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Carfilzomib Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Carfilzomib Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Carfilzomib Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Carfilzomib Revenue (Value) and Growth Rate (2014-2024)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Carfilzomib Type and Applications
Table Amgen Carfilzomib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Natco Basic Information, Manufacturing Base and Competitors
Table Natco Carfilzomib Type and Applications
Table Natco Carfilzomib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Carfilzomib Type and Applications
Table AstraZeneca Carfilzomib Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Carfilzomib Sales by Manufacturer (2017-2018)
Figure Global Carfilzomib Sales Market Share by Manufacturer in 2017
Figure Global Carfilzomib Sales Market Share by Manufacturer in 2018
Table Global Carfilzomib Revenue by Manufacturer (2017-2018)
Figure Global Carfilzomib Revenue Market Share by Manufacturer in 2017
Figure Global Carfilzomib Revenue Market Share by Manufacturer in 2018
Figure Top 3 Carfilzomib Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Carfilzomib Manufacturer (Revenue) Market Share in 2018
Figure Global Carfilzomib Sales and Growth Rate (2014-2019)
Figure Global Carfilzomib Revenue and Growth Rate (2014-2019)
Table Global Carfilzomib Sales by Regions (2014-2019)
Table Global Carfilzomib Sales Market Share by Regions (2014-2019)
Table Global Carfilzomib Revenue by Regions (2014-2019)
Figure Global Carfilzomib Revenue Market Share by Regions (2014-2019)
Figure Global Carfilzomib Revenue Market Share by Regions in 2018
Figure North America Carfilzomib Sales and Growth Rate (2014-2019)
Figure Europe Carfilzomib Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Carfilzomib Sales and Growth Rate (2014-2019)
Figure South America Carfilzomib Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Carfilzomib Sales and Growth Rate (2014-2019)
Figure North America Carfilzomib Revenue and Growth Rate (2014-2019)
Table North America Carfilzomib Sales by Countries (2014-2019)
Table North America Carfilzomib Sales Market Share by Countries (2014-2019)
Figure North America Carfilzomib Sales Market Share by Countries (2014-2019)
Figure North America Carfilzomib Sales Market Share by Countries in 2018
Table North America Carfilzomib Revenue by Countries (2014-2019)
Table North America Carfilzomib Revenue Market Share by Countries (2014-2019)
Figure North America Carfilzomib Revenue Market Share by Countries (2014-2019)
Figure North America Carfilzomib Revenue Market Share by Countries in 2018
Figure United States Carfilzomib Sales and Growth Rate (2014-2019)
Figure Canada Carfilzomib Sales and Growth Rate (2014-2019)
Figure Mexico Carfilzomib Sales and Growth Rate (2014-2019)
Figure Europe Carfilzomib Revenue and Growth Rate (2014-2019)
Table Europe Carfilzomib Sales by Countries (2014-2019)
Table Europe Carfilzomib Sales Market Share by Countries (2014-2019)
Table Europe Carfilzomib Revenue by Countries (2014-2019)
Figure Europe Carfilzomib Revenue Market Share by Countries (2014-2019)
Figure Europe Carfilzomib Revenue Market Share by Countries in 2018
Figure Germany Carfilzomib Sales and Growth Rate (2014-2019)
Figure UK Carfilzomib Sales and Growth Rate (2014-2019)
Figure France Carfilzomib Sales and Growth Rate (2014-2019)
Figure Russia Carfilzomib Sales and Growth Rate (2014-2019)
Figure Italy Carfilzomib Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Carfilzomib Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Carfilzomib Sales by Countries (2014-2019)
Table Asia-Pacific Carfilzomib Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Carfilzomib Sales Market Share by Countries 2018
Table Asia-Pacific Carfilzomib Revenue by Countries (2014-2019)
Figure Asia-Pacific Carfilzomib Revenue Market Share by Countries 2018
Figure China Carfilzomib Sales and Growth Rate (2014-2019)
Figure Japan Carfilzomib Sales and Growth Rate (2014-2019)
Figure Korea Carfilzomib Sales and Growth Rate (2014-2019)
Figure India Carfilzomib Sales and Growth Rate (2014-2019)
Figure Southeast Asia Carfilzomib Sales and Growth Rate (2014-2019)
Figure South America Carfilzomib Revenue and Growth Rate (2014-2019)
Table South America Carfilzomib Sales by Countries (2014-2019)
Table South America Carfilzomib Sales Market Share by Countries (2014-2019)
Figure South America Carfilzomib Sales Market Share by Countries in 2018
Table South America Carfilzomib Revenue by Countries (2014-2019)
Table South America Carfilzomib Revenue Market Share by Countries (2014-2019)
Figure South America Carfilzomib Revenue Market Share by Countries in 2018
Figure Brazil Carfilzomib Sales and Growth Rate (2014-2019)
Figure Argentina Carfilzomib Sales and Growth Rate (2014-2019)
Figure Colombia Carfilzomib Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Carfilzomib Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Carfilzomib Sales by Countries (2014-2019)
Table Middle East and Africa Carfilzomib Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Carfilzomib Sales Market Share by Countries in 2018
Table Middle East and Africa Carfilzomib Revenue by Countries (2014-2019)
Table Middle East and Africa Carfilzomib Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Carfilzomib Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Carfilzomib Revenue Market Share by Countries in 2018
Figure Saudi Arabia Carfilzomib Sales and Growth Rate (2014-2019)
Figure UAE Carfilzomib Sales and Growth Rate (2014-2019)
Figure Egypt Carfilzomib Sales and Growth Rate (2014-2019)
Figure Nigeria Carfilzomib Sales and Growth Rate (2014-2019)
Figure South Africa Carfilzomib Sales and Growth Rate (2014-2019)
Table Global Carfilzomib Sales by Type (2014-2019)
Table Global Carfilzomib Sales Share by Type (2014-2019)
Table Global Carfilzomib Revenue by Type (2014-2019)
Table Global Carfilzomib Revenue Share by Type (2014-2019)
Figure Global 10mg Injection Sales Growth (2014-2019)
Figure Global 10mg Injection Price (2014-2019)
Figure Global 30mg Injection Sales Growth (2014-2019)
Figure Global 30mg Injection Price (2014-2019)
Figure Global 60mg Injection Sales Growth (2014-2019)
Figure Global 60mg Injection Price (2014-2019)
Table Global Carfilzomib Sales by Application (2014-2019)
Table Global Carfilzomib Sales Share by Application (2014-2019)
Figure Global Clinic Sales Growth (2014-2019)
Figure Global Drug Center Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Carfilzomib Sales, Revenue and Growth Rate (2019-2024)
Table Global Carfilzomib Sales Forecast by Regions (2019-2024)
Table Global Carfilzomib Market Share Forecast by Regions (2019-2024)
Figure North America Sales Carfilzomib Market Forecast (2019-2024)
Figure Europe Sales Carfilzomib Market Forecast (2019-2024)
Figure Asia-Pacific Sales Carfilzomib Market Forecast (2019-2024)
Figure South America Sales Carfilzomib Market Forecast (2019-2024)
Figure Middle East and Africa Sales Carfilzomib Market Forecast (2019-2024)
Table Global Carfilzomib Sales Forecast by Type (2019-2024)
Table Global Carfilzomib Market Share Forecast by Type (2019-2024)
Table Global Carfilzomib Sales Forecast by Application (2019-2024)
Table Global Carfilzomib Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
薬物注入装置の世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Drug Injection Devices is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Drug Injection Devices in …- スルファジアジンナトリウム注射の世界市場予測 2024年：メーカー別、地域別、種類・用途別 Scope of the Report: The worldwide market for Sulfadiazine Sodium Injection is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Sulfadiazine Sodium…
- 薬物注入装置市場：世界及び中国の市場分析・予測（～2024年） Drug Injection Devices Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Drug Injection Devices industry with a focus on the Chinese market. The report provides key statistics on the market status of the Drug Injection Devices m…
- 注射用ネダプラチンの世界市場予測 2024年：メーカー別、地域別、種類・用途別（～2024） Scope of the Report: The worldwide market for Nedaplatin for Injection is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Nedaplatin for Injection…
- 世界の皮下注射市場：市場規模・現状・予測 A subcutaneous injection is administered as a bolus into the subcutis, the layer of skin directly below the dermis and epidermis, collectively referred to as the cutis. Subcutaneous injections are highly effective in administering vaccines and medications such as insulin, morphine, diacetylmorphine …